It emerged yesterday that it replaced the two top executives at its Avexis unit, which conducted the preclinical development stages of the drug when the data manipulation allegedly happened.

After receiving FDA breakthrough therapy status for its lead candidate in July, gene therapy company AveXis has released promising new safety and efficacy data. AVXS-101 is being developed to ...

At AveXis, a Novartis company, we have built on 30 years of science to deliver on this challenge by demonstrating the long-term curative potential of gene therapy and its capacity to make an ...